SSStephen Semcho

Stephen Semcho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stephen Semcho has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Different Routes to the Same Destination? Comparing Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Section II- and Alternative Model of Personality Disorder-Defined Borderline Personality Disorder

    by Alexandra Hines, Madeline Kushner, Nicole Stumpp, Stephen Semcho, Eric Bridges, Hannah Croom, Abrar Rahman, Sarah Cecil, Caden Maynard, Matthew W. Southward, et al.

    Borderline personality disorder (BPD) is defined by the presence of at least five of nine symptoms in Section II of the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5). In the DSM-5 Section III Alternative Model of Personality Disorders (AMPD), BPD is defined by deficits in self and/or interpersonal functioning (Criterion A), elevated negative affectivity, and elevated antagonism and/or disinhibition (Criterion B). However, it is unclear if these definitions describe the same people and if the AMPD criteria explain unique variability in treatment outcomes in this population. In a treatment-seeking sample of adult participants diagnosed with BPD according to Section II criteria (n = 65; Mage = 27.60, 70.8% female, 76.9% white), we found a majority (66.2%) would have also received the diagnosis based on AMPD criteria. Those meeting AMPD criteria reported more severe Section II BPD symptoms than those who did not, ps < .02, ds > .60, and the presence or severity of Section II fears of abandonment and inappropriate anger uniquely predicted AMPD BPD diagnoses, ps < .03, ORs > 2.31. Changes in AMPD dimensions explained 34% of the variability in change in work/social adjustment (p = .13) and quality of life (p = .22), respectively, over and above changes in Section II symptoms during a novel cognitive-behavioral treatment for BPD. These results suggest AMPD criteria capture a more severe subset of BPD than Section II criteria and may be important predictors of treatment outcomes. We discuss the potential trade-offs of this shift in diagnosis.

  • Open Access

    Skill use mediates the within-person effect of the alliance on session-to-session changes in anxiety and depression in the Unified Protocol

    by Martina Fruhbauerova, Douglas R. Terrill, Stephen A. Semcho, Nicole E. Stumpp, Jesse P. McCann, Shannon Sauer-Zavala, Matthew W. Southward


  • Within-person changes in aversive reactivity predict session-to-session reductions in anxiety and depression in the unified protocol

    by Stephen A. Semcho, Matthew W. Southward, Nicole E. Stumpp, Michelle M. Smith, Martina Fruhbauerova, Shannon Sauer-Zavala

    The Unified Protocol (UP) theoretically leads to reductions in emotional disorder symptoms by reducing aversive reactions to emotions. However, aversive reactions can take many forms (e.g., non-acceptance, behavioral avoidance). We examined if (1) multiple aspects of aversive reactivity predicted session-to-session changes in anxiety and depression in the UP, (2) these aspects reflected a single latent construct, and (3) changes in this latent construct predicted changes in anxiety and depression. Participants (N = 70, Mage = 33.74, 67.1% female, 74.3% white) completed six sessions of UP modules and measures of aversive reactivity, anxiety, and depression before each session. We used hierarchical linear modeling and random-intercept cross-lagged panel models to test aspects of aversive reactivity and a latent factor of aversive reactivity, respectively, as predictors of session-to-session changes in anxiety and depression. Within-person improvements in four of five aspects of aversive reactivity predicted decreases in anxiety, and improvements in two aspects predicted decreases in depression. However, within-person improvements in latent aversive reactivity predicted decreases in anxiety at five sessions and in depression across all sessions. These results add to the growing literature highlighting the role of aversive reactivity as a potential transdiagnostic process involved in improvements in emotional disorder symptoms during treatment.


  • Open Access

    Within-Person Changes in Aversive Reactivity Predict Session-to-Session Reductions in Anxiety and Depression in the Unified Protocol

    by Stephen Semcho, Matthew W. Southward, Nicole Stumpp, Michelle Smith, Martina Fruhbauerova, Shannon Sauer-Zavala

    The Unified Protocol (UP) theoretically leads to reductions in emotional disorder symptoms by reducing aversive reactions to emotions. However, aversive reactions can take many forms (e.g., non-acceptance, behavioral avoidance). We examined if (1) multiple aspects of aversive reactivity predicted session-to-session changes in anxiety and depression in the UP, (2) these aspects reflected a single latent construct, and (3) changes in this latent construct predicted changes in anxiety and depression. Participants (N = 70, Mage = 33.74, 67.1% female, 74.3% white) completed six sessions of UP modules and measures of aversive reactivity, anxiety, and depression before each session. We used hierarchical linear modeling and random-intercept cross-lagged panel models to test aspects of aversive reactivity and a latent factor of aversive reactivity, respectively, as predictors of session-to-session changes in anxiety and depression. Within-person improvements in four of five aspects of aversive reactivity predicted decreases in anxiety, and improvements in two aspects predicted decreases in depression. However, within-person improvements in latent aversive reactivity predicted decreases in anxiety at five sessions and in depression across all sessions. These results add to the growing literature highlighting the role of aversive reactivity as a potential transdiagnostic process involved in improvements in emotional disorder symptoms during treatment.

  • Conceptual development and case data for a modular, personality-based treatment for borderline personality disorder.

    by Shannon Sauer-Zavala, Matthew W. Southward, Caitlyn O. Hood, Sohayla Elhusseini, Martina Fruhbauerova, Nicole E. Stumpp, Stephen A. Semcho

    Borderline personality disorder (BPD) is a heterogenous condition, and variations in its presentation may be accounted for by individual differences in personality dimensions. Extant treatments for BPD are long term and intensive; it is possible that prioritizing the personality-based difficulties that underlie an individual's symptoms may improve the efficiency of care. This article describes the conceptual background for the development of a novel, personality-based intervention for BPD (BPD Compass), which was informed by recent research on personality mechanisms maintainin this condition, and was designed to address gaps left by existing treatments and to be maximally efficient and disseminable. BPD Compass is a comprehensive, short-term package with a fully modular design that allows for personalization (e.g., all skills can be presented in isolation or in any order based on pretreatment assessment). We discuss the theoretical background for its development, an overview of the skills included in the treatment, as well as preliminary efficacy data. (PsycInfo Database Record (c) 2023 APA, all rights reserved).


  • Open Access

    Aversive Reactivity: A Transdiagnostic Functional Bridge Between Neuroticism and Avoidant Behavioral Coping

    by Stephen A. Semcho, Matthew W. Southward, Nicole E. Stumpp, Destiney L. MacLean, Caitlyn O. Hood, Kate Wolitzky-Taylor, Shannon Sauer-Zavala

    Aversive reactivity to negative affect has been described as a transdiagnostic mechanism that links distal temperamental vulnerabilities to clinically relevant behaviors. However, the abundance of constructs reflecting aversive reactivity has resulted in a proliferation of models that may ultimately be redundant. We performed a circumscribed review of studies measuring associations between six constructs – anxiety sensitivity, experiential avoidance, distress intolerance, intolerance of uncertainty, thought-action fusion, and negative urgency – and ten relevant coping behaviors. Results suggested that most constructs were measured in relation to a limited number of coping behaviors. Additionally, constructs were most often measured in isolation, rather than with similar constructs. Implications and suggestions for future research and treatment are discussed.


  • Open Access

    Mechanism Engagement as a Potential Evidence-Based Approach to Personalized Treatment Termination

    by Shannon Sauer-Zavala, Matthew W. Southward, Douglas Terrill, Stephen Semcho, Nicole Stumpp

    Objective: This study explores whether early change on a putative mechanism maintaining symptoms can serve a proximal indicator of response to prompt discontinuation. Method: Participants (N = 70) with heterogeneous anxiety and depressive disorders were enrolled in a pilot sequential multiple assignment randomized trial (SMART). Patients received 6 sessions of skill modules from the Unified Protocol and then underwent a second-stage randomization to either receive the remaining 6 sessions (Full duration) or discontinue treatment (Brief duration). All participants completed weekly self-report measures of anxiety and depressive symptoms (Overall Anxiety Severity and Interference Scale; Overall Depression Severity and Interference Scale) and distress aversion (Multidimensional Experiential Avoidance Questionnaire) for the full treatment window (i.e., 12 weeks). We used structural equation modeling to test (1) if distress aversion demonstrated significant variability during the first-stage randomization and (2) if distress aversion during the first-stage randomization predicted second-stage changes in anxiety and depression. Results: Participants demonstrated significant variability in first-stage distress aversion. Latent distress aversion slopes significantly predicted latent second-stage anxiety slopes, whereas latent distress aversion intercepts significantly predicted latent second-stage depression slopes. Conclusions: These results suggest that it may be possible to use early mechanism engagement as a trigger that prompts personalized termination. Shorter courses of care have the potential to reduce patient costs and increase the mental health service system’s capacity.

  • Mechanism engagement as a potential evidence-based approach to personalized treatment termination

    by Shannon Sauer-Zavala, Matthew W. Southward, Doug R. Terrill, Stephen A. Semcho, Nicole E. Stumpp

    This study explores whether early change on a putative mechanism maintaining symptoms can serve as a proximal indicator of response to prompt discontinuation.Patients (N = 70; Mage = 33.74, 67% fem...


  • Open Access

    BPD Compass: A Randomized Controlled Trial of a Short-Term, Personality-Based Treatment for Borderline Personality Disorder

    by Shannon Sauer-Zavala, Matthew W. Southward, Martina Fruhbauerova, Stephen Semcho, Nicole Stumpp, Caitlyn O. Hood

    Borderline personality disorder (BPD) is a heterogeneous condition that can be understood as the manifestation of three personality dimensions: neuroticism (i.e., high negative affectivity), agreeableness (i.e., low antagonism), and conscientiousness (i.e., low disinhibition). The purpose of the present study was to explore whether treatment with BPD Compass, a novel personality-based intervention for BPD, results in greater reductions in BPD symptoms, neuroticism, agreeableness, and conscientiousness compared to a waitlist control (WLC) condition. We also aimed to characterize within-treatment effects for participants assigned to the BPD Compass condition and evaluate patients’ satisfaction with treatment. Participants (N = 51; Mage = 28.38; 83.3% female; 93.8% white; 54.2% sexual minority) meeting DSM-5 criteria for BPD were enrolled in a randomized controlled trial to evaluate the efficacy of BPD Compass. Patients were randomly assigned to receive 18 sessions of BPD Compass or complete an 18-week waiting period. BPD Compass led to larger reductions in BPD symptoms (assessor-rated [ = –.47] and self-reported [ = –.62]) and neuroticism (β = –.37), but not agreeableness (β = .08) or conscientiousness (β = .10), compared to the WLC condition. Within the BPD Compass condition, pre- to post-treatment improvements in BPD symptoms, neuroticism, and conscientiousness were significant and large in magnitude (Hedges’ gs: –1.38- –1.08). Patients were highly satisfied with BPD Compass and generally perceived it to be an appropriate length. Thus, BPD Compass may be an accessible and useful complement to more specialty or intensive treatments for BPD.

  • A SMART approach to personalized care: preliminary data on how to select and sequence skills in transdiagnostic CBT

    by Shannon Sauer-Zavala, Matthew W. Southward, Nicole E. Stumpp, Stephen A. Semcho, Caitlyn O. Hood, Anna Garlock, Alex Urs

    Given that over 20 million adults each year do not receive care for their mental health difficulties, it is imperative to improve system-level capacity issues by increasing treatment efficiency. The present study aimed to collect feasibility/acceptability data on two strategies for increasing the efficiency of cognitive behavioral therapy: (1) personalized skill sequences and (2) personalized skill selections. Participants (N = 70) with anxiety and depressive disorders were enrolled in a pilot sequential multiple assignment randomized trial (SMART). Patients were randomly assigned to receive skill modules from the Unified Protocol in one of three sequencing conditions: standard, sequences that prioritized patients’ relative strengths, and sequences that prioritized relative deficits. Participants also underwent a second-stage randomization to either receive 6 sessions or 12 sessions of treatment. Participants were generally satisfied with the treatment they received, though significant differences favored the Capitalization and Full duration conditions. There were no differences in trajectories of improvement as a function of sequencing condition. There were also no differences in end-of-study outcomes between brief personalized treatment and full standard treatment. Thus, it may be feasible to deliver CBT for personalized durations, though this may not substantially impact trajectories of change in anxiety or depressive symptoms.